These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37097451)

  • 1. Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
    Bae JS; Lee JY; Suh KS; Hong SK; Yoon JH; Kim YJ; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK
    Abdom Radiol (NY); 2023 Jul; 48(7):2321-2330. PubMed ID: 37097451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
    Joo I; Kim SY; Kang TW; Kim YK; Park BJ; Lee YJ; Choi JI; Lee CH; Park HS; Lee K; Kim H; Yu E; Kang HJ; Ha SY; Kim JY; Ahn S; Jung ES; Kim BH; Han HS; Lee JM
    Radiology; 2020 Aug; 296(2):335-345. PubMed ID: 32484414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.
    Park HJ; Lee TY; Kim SY; Kim MJ; Singal AG; Lee SJ; Won HJ; Byun JH; Lim YS
    Eur Radiol; 2022 Aug; 32(8):5064-5074. PubMed ID: 35229195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis.
    Kim TH; Woo S; Han S; Suh CH; Lee DH; Lee JM
    Eur Radiol; 2020 Mar; 30(3):1624-1633. PubMed ID: 31776747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Hypervascularization in Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement: A Systematic Review and Meta-analysis.
    Kim TH; Woo S; Han S; Suh CH; Do RKG; Lee JM
    Acad Radiol; 2022 Feb; 29(2):198-210. PubMed ID: 32962925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk.
    Kang HJ; Lee JM; Yoon JH; Lee K; Kim H; Han JK
    Radiology; 2020 Oct; 297(1):108-116. PubMed ID: 32749211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation.
    Cannella R; Calandra A; Cabibbo G; Midiri M; Tang A; Brancatelli G
    Eur J Radiol; 2019 Nov; 120():108689. PubMed ID: 31563835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perfluorobutane-enhanced ultrasonography with a Kupffer phase: improved diagnostic sensitivity for hepatocellular carcinoma.
    Hwang JA; Jeong WK; Kang HJ; Lee ES; Park HJ; Lee JM
    Eur Radiol; 2022 Dec; 32(12):8507-8517. PubMed ID: 35705829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Washout appearance of hepatocellular carcinomas using standardized contrast-enhanced ultrasound (CEUS) including an extended late phase observation - Real-world data from the prospective multicentre DEGUM study.
    Meitner-Schellhaas B; Jesper D; Goertz RS; Zundler S; Strobel D
    Clin Hemorheol Microcirc; 2023; 84(4):413-424. PubMed ID: 37334585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.
    Kang HJ; Lee JM; Yoon JH; Han JK
    Korean J Radiol; 2021 Mar; 22(3):354-365. PubMed ID: 33236540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs.
    Paisant A; Vilgrain V; Riou J; Oberti F; Sutter O; Laurent V; Rodes A; Guiu B; Cassinotto C; Trillaud H; Bricault I; Michalak S; Bruno O; Ronot M; Aubé C
    J Hepatol; 2020 May; 72(5):937-945. PubMed ID: 31870951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
    Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
    Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
    Li L; Zheng W; Wang J; Han J; Guo Z; Hu Y; Li X; Zhou J
    AJR Am J Roentgenol; 2022 Sep; 219(3):434-443. PubMed ID: 35441534
    [No Abstract]   [Full Text] [Related]  

  • 15. Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?
    Joo I; Lee JM; Lee DH; Jeon JH; Han JK
    Eur Radiol; 2019 Apr; 29(4):1724-1732. PubMed ID: 30255250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement as a risk factor for late recurrence (>1 year) of hepatocellular carcinoma after surgery.
    Matsuda M; Ichikawa S; Matsuda M; Amemiya H; Ichikawa D; Onishi H; Motosugi U
    Clin Radiol; 2019 Dec; 74(12):975.e1-975.e9. PubMed ID: 31540704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound (CEUS) - a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS HCC trial.
    Strobel D; Agaimy A; Jesper D; Zundler S; Schellhaas B
    Ultraschall Med; 2023 Dec; 44(6):606-613. PubMed ID: 36781161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane: LI-RADS for Diagnosing Hepatocellular Carcinoma.
    Li L; Zou X; Zheng W; Li Y; Xu X; Li K; Su Z; Han J; Li Q; Zuo Y; Xie S; Wen H; Wang J; Guo Z; Zou R; Zhou J
    Radiology; 2023 Aug; 308(2):e230150. PubMed ID: 37642573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved diagnostic algorithm for subcentimeter hepatocellular carcinoma on gadoxetic acid-enhanced MRI.
    Huang P; Zhou C; Wu F; Xiao Y; Qian X; Wang Y; Yang C; Zeng M
    Eur Radiol; 2023 Apr; 33(4):2735-2745. PubMed ID: 36472696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.
    Kozaka K; Kobayashi S; Yoneda N; Kitao A; Yoshida K; Inoue D; Ogi T; Koda W; Sato Y; Gabata T; Matsui O
    Eur Radiol; 2019 Dec; 29(12):6489-6498. PubMed ID: 31278576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.